Copernicus Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Copernicus Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.14M	Buy	+2,000	New	+$1.1M	13.83%	2
2020 Q2	–	Sell	-18,896	Closed	-$5.36M	–	24
2020 Q1	$5.36M	Buy	18,896 +8,937	+90%	+$2.82M	6.48%	8
2019 Q4	$3.23M	Sell	9,959 -19,017	-66%	-$5.77M	4.24%	9
2019 Q3	$8.44M	Sell	28,976 -7,000	-19%	-$2M	7.85%	7
2019 Q2	$10.6M	Buy	35,976 +16,986	+89%	+$4.68M	9.4%	5
2019 Q1	$5.2M	Sell	18,990 -10	-0.1%	-$2.49K	13.33%	1
2018 Q4	$4.25M	Sell	19,000 -1,206	-6%	-$283K	8%	6
2018 Q3	$4.93M	Sell	20,206 -35,439	-64%	-$8.15M	4.63%	10
2018 Q2	$11.5M	Buy	55,645 +11,645	+26%	+$2.47M	8.37%	2
2018 Q1	$9.08M	Buy	+44,000	New	+$9.24M	7.24%	5

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Copernicus Capital Management's TMO Position: Q3 2021 in Review

Copernicus Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q3 2021: 2,000 shares worth $1.14M. The stake represents 13.83% of the portfolio and ranks #2 among its holdings. This is a return to the name: Copernicus Capital Management previously reported a position in TMO as recently as Q1 2020.

Copernicus Capital Management first reported a position in TMO in Q1 2018 and has held it in 10 quarters since. The position peaked at $11.5M in Q2 2018. 2,128 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

Copernicus Capital Management held 2,000 shares of Thermo Fisher Scientific worth $1.14M as of Q3 2021.
Thermo Fisher Scientific was a new Copernicus Capital Management position in Q3 2021.
Thermo Fisher Scientific made up 13.83% of Copernicus Capital Management's portfolio in Q3 2021, its #2 holding.
Copernicus Capital Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 10 quarters since.
Copernicus Capital Management's Thermo Fisher Scientific position peaked at $11.5M in Q2 2018.
2,128 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Copernicus Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.